SG11201808514YA - Method for designing mutant primer - Google Patents

Method for designing mutant primer

Info

Publication number
SG11201808514YA
SG11201808514YA SG11201808514YA SG11201808514YA SG11201808514YA SG 11201808514Y A SG11201808514Y A SG 11201808514YA SG 11201808514Y A SG11201808514Y A SG 11201808514YA SG 11201808514Y A SG11201808514Y A SG 11201808514YA SG 11201808514Y A SG11201808514Y A SG 11201808514YA
Authority
SG
Singapore
Prior art keywords
primer
nucleotide residue
region
loop structure
designing
Prior art date
Application number
SG11201808514YA
Other languages
English (en)
Inventor
Makoto Takaishi
Original Assignee
Daiken Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiken Medical Co Ltd filed Critical Daiken Medical Co Ltd
Priority claimed from PCT/JP2017/004162 external-priority patent/WO2017169119A1/ja
Publication of SG11201808514YA publication Critical patent/SG11201808514YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201808514YA 2016-03-30 2017-02-06 Method for designing mutant primer SG11201808514YA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016067252 2016-03-30
JP2016154013A JP6681804B2 (ja) 2016-03-30 2016-08-04 変異プライマーの設計方法
PCT/JP2017/004162 WO2017169119A1 (ja) 2016-03-30 2017-02-06 変異プライマーの設計方法

Publications (1)

Publication Number Publication Date
SG11201808514YA true SG11201808514YA (en) 2018-10-30

Family

ID=60044331

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201808514YA SG11201808514YA (en) 2016-03-30 2017-02-06 Method for designing mutant primer

Country Status (8)

Country Link
US (1) US20190144933A1 (ko)
EP (1) EP3438257A4 (ko)
JP (1) JP6681804B2 (ko)
KR (1) KR20180129806A (ko)
CN (1) CN109072221A (ko)
CA (1) CA3019468A1 (ko)
SG (1) SG11201808514YA (ko)
ZA (1) ZA201806890B (ko)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2230631T3 (es) * 1997-03-20 2005-05-01 F. Hoffmann-La Roche Ag Cebadores modificados.
US6277607B1 (en) * 1999-05-24 2001-08-21 Sanjay Tyagi High specificity primers, amplification methods and kits
DE60115811T2 (de) * 2000-10-25 2006-08-03 Roche Diagnostics Gmbh Amplifizierung unter Verwendung von modifizierten Primern
CN101171343A (zh) * 2005-04-14 2008-04-30 阿普里拉股份有限公司 含有假异胞嘧啶核碱基衍生物的3’修饰寡核苷酸及其作为引物或探针的应用
ES2647237T3 (es) * 2007-07-03 2017-12-20 Genaphora Ltd. Cebadores quiméricos para reacciones de amplificación de ácidos nucleicos mejoradas
KR101110013B1 (ko) * 2007-10-05 2012-02-29 (주)바이오니아 서열 내에 어베이직 부분을 포함하는 pcr 증폭용프라이머
US9783844B2 (en) * 2012-04-27 2017-10-10 Kaneka Corporation Method for amplifying nucleic acid and method for detecting amplified nucleic acid
AU2012384852B2 (en) * 2012-07-03 2015-10-08 Mackay Memorial Hospital Self-competitive primer and method of use
WO2017144457A1 (en) * 2016-02-25 2017-08-31 F. Hoffmann-La Roche Ag Elimination of primer-primer interactions during primer extension

Also Published As

Publication number Publication date
CA3019468A1 (en) 2017-10-05
US20190144933A1 (en) 2019-05-16
JP2017184710A (ja) 2017-10-12
ZA201806890B (en) 2020-01-29
CN109072221A (zh) 2018-12-21
EP3438257A4 (en) 2019-10-23
EP3438257A1 (en) 2019-02-06
JP6681804B2 (ja) 2020-04-15
KR20180129806A (ko) 2018-12-05

Similar Documents

Publication Publication Date Title
MX2024002873A (es) Metodos y composiciones para el enriquecimiento de productos de amplificacion.
MX2022005119A (es) Metodos de reduccion de olor.
TW200700362A (en) Process for producing an organic compound
SG10201900355RA (en) Polypeptide for hydrolytic cleavage of zearalenone and/orzearalenone derivatives, isolated polynucleotide thereof as wellas a polypeptide containing an additive, use of same as well as aprocess
NZ631512A (en) Compositions and methods for modulating apolipoprotein (a) expression
PH12015502388A1 (en) Compositions and methods for altering second messenger signaling
TW200630385A (en) Process for the polymerisation of vinyl-containing monomers
MX2021013038A (es) Composiciones que contienen hfo-1234ze, hfo-1225zc y hfo-1234yf y procesos para producir y usar las composiciones.
IN2014CN04648A (ko)
MX2013012079A (es) Emulsion de cera para uso en productos para la construccion.
MX363238B (es) Proceso enzimatico para obtener 17 alfa-monoesteres de cortexolona y/o sus 9,11-dehidroderivados.
GB2489187A (en) Compositions,methods and related uses for cleaving modified DNA
PH12020551663A1 (en) Genetic loci associated with increased fertility in maize
MX2019004460A (es) Artículo corroible de fondo de pozo.
EA201890379A1 (ru) Терапевтические олигонуклеотиды
WO2014068409A3 (en) Use of a cement accelerator and electric arc furnace dust in cement
MX2013004354A (es) Kit para detectar el virus de la leucemia bovina (blv), y uso del mismo.
BR112018013323A2 (pt) molécula de ácido nucleico, inibidor de expressão, medicamento, agente terapêutico, método para inibir expressão de um gene pró-renina ou um gene receptor pró-renina, e, uso de uma molécula de ácido nucleico.
PH12015501176B1 (en) Primers, snp markers and method for genotyping mycobacterium tuberculosis
IN2012DN05209A (ko)
RU2016130093A (ru) Трансформант для экспрессии цис-пренилтрансферазы и рецептора Nogo-B
MX2018002031A (es) Proceso para la preparacion de 1,4-bis (etoximetil) ciclohexano.
MX2009009831A (es) Nitrilos aromatizantes.
SG11201808514YA (en) Method for designing mutant primer
BR112017008702A2 (pt) ?mutante de endoxilanase, dna, vetor, célula, método de produção de mutantes de endoxilanase, composição enzimática e método de produção de solução de açúcar?